ProPhase Labs, Inc. Income Taxes Paid
ProPhase Labs, Inc. (PRPH) reported Income Taxes Paid of $1.35 million for the 12-month period ending 2017-12-31, per its 10-K/A filed 2018-08-20.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2018-08-20
- ProPhase Labs, Inc. income taxes paid for the quarter ending 2017-12-31 was $0.00.
- ProPhase Labs, Inc. income taxes paid for the quarter ending 2017-09-30 was $0.00.
- ProPhase Labs, Inc. income taxes paid for the quarter ending 2011-12-31 was $0.00, a 100.00% decline year-over-year.
- ProPhase Labs, Inc. income taxes paid for the quarter ending 2011-09-30 was $0.00.
- ProPhase Labs, Inc. income taxes paid for fiscal 2017 was $1.35M.
- ProPhase Labs, Inc. income taxes paid for fiscal 2013 was $0.00.
- ProPhase Labs, Inc. income taxes paid for fiscal 2012 was $0.00.
- ProPhase Labs, Inc. income taxes paid for fiscal 2011 was $0.00, a 100.00% decline from fiscal 2010.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-08-20 | $0.00 derived: sum of 2 quarters · filed 2018-08-20 | $1.35M 10-K/A · filed 2018-08-20 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2017-11-13 | $1.35M 10-Q · filed 2017-11-13 | ||
| 2017-06-30 | $1.35M 10-Q/A · filed 2018-08-20 | |||
| 2013-12-31 | $0.00 10-K · filed 2014-03-27 | |||
| 2012-12-31 | $0.00 10-K · filed 2014-03-27 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $0.00 derived: sum of 2 quarters · filed 2014-03-27 | $0.00 10-K · filed 2014-03-27 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | ||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-12 | |||
| 2010-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $34.00K derived: sum of 2 quarters · filed 2013-03-28 | $34.00K 10-K · filed 2013-03-28 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-12 | |||
| 2009-12-31 | $43.00K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |